Business: Insurance

SmartFinancial Wins WMA’s WebAward Competition for ‘Outstanding Website’

Leave a comment



COSTA MESA, Calif. (PRWEB)

SmartFinancial, a leading insurance technology company, announced today that it just won the 2019 WebAward for Outstanding Achievement in Web Development. Since 1997, the Web Marketing Association (WMA) has held an annual competition and set the standards of excellence for website development. Only the best are recognized with a WebAward.

SmartFinancial’s Creative Director, Kevin Lucius, is thrilled about the announcement: “We are honored to receive this recognition. It’s been our goal from day one to create an amazing customer experience and I am very proud of all the hard work our team has done.”

SmartFinancial focuses on providing valuable content, actionable advice and rich tools to help insurance customers compare and find the best insurance coverage for auto, home, commercial, health and life. Its mission is to provide consumers clarity and savings with its insightful data and intelligent carrier-matching process. The company provides a similar resource for insurance partners as they adopt the new technology platform to reach these consumers. SmartFinancial operates an innovative real-time marketplace that gives insurance clients the ability to acquire insurance customers, optimize marketing campaigns and maximize ROI.

Founded by a team of insurance and technology experts, SmartFinancial focuses on delivering measurable results and exceptional service. With offices in Columbus, OH and Costa Mesa, CA, the company ranked 227 on Deloitte’s Technology Fast 500™.

For more information on the WMA WebAwards, visit: http://www.webaward.org/

Share article on social media or email:



Source link

Business: Executives

Financial Poise™ Announces “How to Value Your Assets,” a New Webinar Premiering October 11th at 11:00 AM CST through West LegalEdcenter™

Leave a comment


News Image

This webinar provides an overview of how valuation experts go about valuing a going concern.


CHICAGO (PRWEB)

A business owner or executive team may want to obtain an independent appraisal before going out to market to sell a business. Likewise, a prospective buyer may wish to use the services of an expert to value an acquisition target or discrete components of a target. This webinar provides an overview of how valuation experts go about valuing a going concern. It also covers recent trends in valuation multiples, approaches, value drivers, how synergies are factored into transaction values and how minority holdings in business may be discounted.

To learn more, click here.

The webinar will be available on-demand after its premiere. As with every Financial Poise Webinar, it will be an engaging and plain English conversation designed to entertain as it teaches.

About Financial Poise –

Financial Poise has one mission: to provide reliable plain English business, financial and legal education to investors, private business owners and executives, and their respective trusted advisors. Financial Poise content is created by seasoned, respected experts who are invited to join our Faculty only after being recommended by current Faculty Members. Our editorial staff then works to make sure all content is easily digestible. Financial Poise is a meritocracy; nobody can “buy” their way into the Financial Poise Faculty. Start learning today at https://www.financialpoise.com/

Share article on social media or email:



Source link

Health: Addiction

$1 Million Awarded for Prevention, Treatment and Recovery Efforts to ‘Fight’ Opioid Addiction in Stephens County Through “HOPE” Initiative

Leave a comment


“This award is an asset that will provide much-needed funding for prevention, treatment, and recovery efforts to ‘fight’ opioid addiction, reduce the high rate of fatal overdose here in Stephens County and make a positive impact on people’s lives in our community,” -Kathy Whitmire.


STEPHENS COUNTY, Ga. (PRWEB)

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), has awarded $1 million to the Stephens County Mental Health Collaborative, in partnership with the Georgia Partnership for Telehealth, to fund the efforts of the “HOPE for a Drug Free Stephens Initiative” started in 2018 to mitigate the effects of the opioid crisis on individuals and families in Stephens County. The $1 million award was issued by HRSA to Georgia Partnership for Telehealth (GPT), which will be the fiscal agent and coordinator of the grant funds and will oversee its execution. The funds will cover expenses needed for programming and services over a three-year period of performance. “It is an honor to partner with Stephens County in this endeavor to improve outcomes and access to Opioid Use Disorder Treatment and recovery through telehealth solutions,” said GPT’s COO and Grant Project Director Sherrie Williams.

The members of the Stephens County Mental Health Consortium include Georgia Partnership for Telehealth, Stephens County Hospital Emergency Department, Avita Community Partners, Stephens County Sheriff, Toccoa Police Department, Stephens County EMS, Open Arms Free Clinic, Toccoa Clinic, Family Connections, Stephens County Hospital Physicians, Stephens County Development Authority, and local business leaders and supporting organizations committed to improving access to mental health services, and to reducing the overdose death rate in Stephens County from the use of opiates and controlled substances.

“This award is an asset that will provide much-needed funding for prevention, treatment, and recovery efforts to ‘fight’ opioid addiction, reduce the high rate of fatal overdose here in Stephens County and make a positive impact on people’s lives in our community,” said Consortium Co-chair and Grant Program Manager, Kathy Whitmire.

In 2018 the County Health Rankings website reported an average of 16 fatal opioid and related substance use overdoses annually in Stephens County. Stephens County Emergency Department reported 117 non-fatal opioid/SUD overdoses. The goal of the consortium’s HOPE Initiative is to strengthen our community’s capacity to change the skyrocketing trend in years of potential life lost by targeting more integrated and comprehensive substance use disorder/opioid use disorder (SUD/OUD) prevention, treatment and recovery support.

As an award recipient, the Consortium’s goal will be to implement a set of core SUD/OUD prevention, treatment, and recovery activities that align with the U.S. Department of Health and Human Services’ (HHS) Five-Point Strategy to Combat the Opioid Crisis. 

To meet this goal, the Consortium identified the following steps in its grant request:

Prevention: The HOPE Initiative will reduce the occurrence and associated risk of OUD among new and at-risk users, as well as fatal opioid-related overdoses through community and provider education, harm reduction strategies, and referral to treatment and recovery support services.

Treatment: The HOPE Initiative will implement and expand access to evidence-based practices, including medication-assisted treatment (MAT) with psychosocial intervention, and eliminate or reduce treatment costs for uninsured and underinsured patients.

Recovery: The HOPE Initiative will expand access to recovery and treatment options that help people in Stephens County battling OUD and will track the number that start and stay in recovery, including socio-economic assessment to ensure access to support services such as transportation, housing, peer recovery, case management, employment assistance, and childcare.

For More Information Contact:

Kathy Whitmire, Co-Chair and Grant Program Manager – 706-491-3493

Stephens County Mental Health Collaborative and HOPE for a Drug-Free Stephens

“This project (grant # GA1RH33505) is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $1M. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.”

Share article on social media or email:



Source link

Health

Center for Vein Restoration Joined by Alabama Vein Specialist, Veteran – Dr. Rodney Sirk

Leave a comment


News Image

At CVR we focus exclusively on treating venous insufficiency, so we are proud to have a dedicated Phlebologist like Dr. Sirk join our team.


GREENBELT, Md. (PRWEB)

Center for Vein Restoration (CVR) is proud to announce the addition of Rodney A. Sirk, MD, RVT, RPhS to its expanding and esteemed roster of physicians treating venous disease throughout the country. His practice in Fairhope will be the third CVR location in Alabama alongside Dr. Kenneth Todd’s Dothan practice and Dr. Michael Aikens’ practice in Opelika. Dr. Rodney Sirk comes to CVR after a 20-year medical career, dedicated primarily to Phlebology. He has operated Fairhope Vein Treatment Center LLC, an independent vein practice, since 2014.

Dr. Sirk joined the US Air Force after high school where he spent seven years as an enlisted Airman and served as an Aeromedical Evacuation Specialist in Operation Desert Storm. After receiving an honorable discharge in 1991, he entered the Marshall University’s School of Medicine in Huntington. Dr. Sirk graduated in 1995 and completed his residency in Family Medicine at Marshall University in 1998.

In the first decade of his career, Dr. Sirk focused on general medicine (inpatient, ICU, and outpatient). After completing additional training in Birmingham, Alabama, he transitioned to focus entirely on Phlebology in 2010. Dr. Sirk is a Diplomate of the American Board of Venous and Lymphatic Medicine, and a member of the American Vein and Lymphatic Society and the American Venous Forum. He also specializes in ultrasound imaging as a Registered Vascular Technician and a Registered Phlebology Sonographer.

Dr. Sanjiv Lakhanpal, CEO; Dr. Khanh Q. Nguyen, Chief Medical Officer; Ken Abod, CFO; and Neil Collier, Chief Operating Officer, at CVR are all pleased to welcome Dr. Sirk to the company. “At CVR we focus exclusively on treating venous insufficiency, so we are proud to have a dedicated Phlebologist like Dr. Sirk join our team,” added Dr. Lakhanpal.

Dr. Sirk’s accomplishments and accreditations also include:

·    Former Owner and Chief Medical Officer, Fairhope Vein Treatment Center

·    Recipient, National Defense Service Medal (1991); US Air Force Achievement Medal (1984)

ABOUT VENOUS INSUFFICIENCY

Venous insufficiency, the cause of significant suffering due to the sequelae of venous hypertension, most commonly arises as achy, tired and heavy legs. It may or may not be associated with varicose veins, spider veins or skin changes including venous ulcerations and indiscriminately affects between 30–40 million Americans. Numerous factors including age, weight, prolonged sitting or standing, genetics or a history of DVT (blood clots) can increase the risk of developing this common and often underdiagnosed disorder. Treatment options have evolved to an array of minimally invasive procedures in an office setting.

ABOUT CENTER FOR VEIN RESTORATION

Center for Vein Restoration (CVR) is the largest physician-led practice treating vein disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 82 centers and growing, CVR has over 500 employees and conducts over 150,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.

Share article on social media or email:



Source link

Science: Biology

Catalent Announces the Appointment of David Schaffer to Biologics Advisory Board

Leave a comment


We welcome David to the advisory board and look forward to his insights and guidance at this exciting time in the company’s evolution as we embrace the new technology of gene therapy into the services we offer.


SOMERSET, N.J. (PRWEB)

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced that professor David Schaffer has been appointed to the advisory board of the company’s biologics business. Dr. Schaffer has played an integral advisory role on the gene therapy industry, as Catalent has moved into gene therapy services through the company’s May 2019 $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies.

“We welcome David to the advisory board and look forward to his insights and guidance at this exciting time in the company’s evolution as we embrace the new technology of gene therapy into the services we offer,” commented Mike Riley, Vice President and General Manager of Catalent Biologics. “David’s depth of knowledge and expertise in this area will complement our team, especially advising on the new viral vector development and manufacturing technologies we have gained through our acquisition of Paragon Bioservices, Inc.”

The biologics advisory board was originally founded in 2015 to bring together scientific thought leaders and biotechnology industry veterans to strengthen and support Catalent’s growth in the rapidly evolving field. Professor Schaffer joins the current board’s members, Carolyn Bertozzi, Ph.D., Barry Buckland, Ph.D., Michael Buckley, Ph.D., Daniel R. Marshak, Ph.D., Edward R. Robinson, and Matthew Stober.

Professor Schaffer serves as Director of the Berkeley Stem Cell Center, in addition to holding a position as a professor of chemical and biomolecular engineering, bioengineering, and neuroscience at University of California, Berkeley. He completed his bachelor’s at Stanford University, before undertaking his doctorate at the Massachusetts Institute of Technology, and postdoctoral training at the Salk Institute. His research at Berkeley applies engineering principles to enhance gene therapy and stem cell approaches to treat human disease.

He is the co-founder of three companies: 4D Molecular Therapeutics, Inc., which uses a novel technology platform to engineer optimized, proprietary adeno-associated viral (AAV) vectors for gene therapy; Ignite Immunotherapies, Inc., which is developing novel oncolytic virus technologies as cancer therapies in partnership with Pfizer; and Valitor, Inc., which is developing a novel protein-polymer conjugation technology to develop greatly enhanced protein biologics for a range of disease targets.

Catalent Biologics provides advanced technologies and integrated solutions for biologic and biosimilar development and manufacturing, from DNA to fill/finish and commercial supply, through its extensive Biologics network including: Bloomington, Indiana, where the company recently announced a twenty-first commercial launch of a fill/finish product, and; Madison, Wisconsin, home of Catalent Biologics’ proprietary GPEx® technology for stable, high-yielding mammalian cell lines with twelve approved molecules. For more information on Catalent Biologics, visit biologics.catalent.com.

About Catalent Biologics

For more than two decades, Catalent Biologics has built capabilities and experience in development, manufacturing, and analytical services for new biological entities, gene therapies, biosimilars, and antibody-drug conjugates. Catalent Biologics has worked with 600+ mAbs and 80+ proteins, and 12 biopharmaceutical drugs produced using GPEx® technology have been approved and marketed, with more than 120 ongoing clinical trials utilizing therapeutic candidates developed using the GPEx platform. A further 25 commercially-approved products have employed Catalent Biologics’ capabilities through to aseptic fill/finish. Catalent Biologics’ latest addition, Paragon Gene Therapy’s AAV development through commercial-scale manufacturing facilities in Baltimore, Maryland, have produced over 100 clinical GMP batches across 40 programs. Using advanced technology and tailored solutions for clinical through commercial supply, Catalent Biologics brings better biologic treatments to patients, faster. For more information, visit biologics.catalent.com

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including over 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:



Source link

Technology: Computer

Teracube Launches on Kickstarter Bringing a Sustainable, Affordable Smartphone to Market

Leave a comment


News Image

I’ve always envisioned changing the disposable nature of the consumer electronics industry by designing high-quality products that last longer,” said Sharad Mittal, Co-Founder of Teracube. “We want to talk about our footprint and show people how small changes can make a huge impact.


REDMOND, Wash. (PRWEB)

Teracube launches today on Kickstarter bringing an affordable smartphone with a fast octa-core processor, dual rear cameras, dual back cameras, high-speed processing and extensive storage space to tech lovers everywhere. Teracube is also the world’s first and only cutting-edge smartphone that comes with a 4-year warranty.

“I’ve always envisioned changing the disposable nature of the consumer electronics industry by designing high-quality products that last longer,” said Sharad Mittal, Co-Founder of Teracube. “This is why we are offering a four-year warranty on Teracube. We want to talk about our footprint and show people how small changes can make a huge impact.”

Teracube’s 4-year warranty promises high performance for years to come. It not only eliminates the typical investment of a new phone every few years, but it also ensures users can keep one piece of personal technology for a longer period of time. In turn, this can significantly decrease the amount of electronic waste over time.

With Teracube, users don’t have to worry about sacrificing typical smartphone features. In fact, Teracube’s dual rear cameras take vivid and sharp pictures. One camera captures the depth of the objects while the second captures vibrant colors and other details. The front camera utilizes artificial intelligence technology to take beautiful self portraits that users can share with the world.

Teracube also has an octa-core processor which enables it to carry out more advanced tasks, such as handling high resolution videos and graphic-heavy games without draining the battery. The octa-core processor also gives Teracube a much faster load time. With 128GB of storage and 6GB RAM, users won’t have to worry about running out of space and can experience great performance for years to come. Plus, with its 3400 mAh battery, Teracube will stay charged throughout the day. Last but not least, Teracube’s 6.2” Full HD+ IPS display, Teracube offers an immersive viewing experience.

In terms of durability, Teracube’s display is constructed with sturdy Gorilla Glass to handle the demands of everyday life. The metal alloy frame provides ultimate strength making Teracube long lasting. Teracube is backed by hassle-free warranty, covering all parts, performance, labor, and two-way shipping at no cost. It even includes free battery change and express replacement. Teracube will be available for pre-order on Kickstarter for $175 (MSRP $349). The screen size is 6.2” and the phone is 157mm x 75.5mm x 7.7mm. The phone supports AT&T, MetroPCS, T-Mobile, Cricket, Lyca and more. For more information about the campaign, or to place a pre-order, please visit pr.go2.fund/teracube.

About Teracube Inc.

Teracube is an innovative technology development company out of Redmond, Washington. The founders Sharad Mittal and Anthony Tsim are both excited to bring Teracube to market. Mittal is a passionate environmentalist and has more than 10 years of experience in consumer electronics design and retail, and more than 10 years in software development. They want to have a different conversation with their customers than most other brands. Teracube wants to create awareness on the environmental impact due to the vast amount of e-waste produced from the growing number of discarded phones. They believe small changes can make a huge difference for our planet. For more information, visit http://www.myteracube.com.

Share article on social media or email:



Source link

Technology: Electronics

New Interactive Product Platform from Radco Industries

Leave a comment


https://www.prweb.com/

The fluid directory page features an interactive temperature graphic displaying the recommended temperature service ranges for all the heat transfer fluids.

Radco’s new Interactive Product Platform, located on their website, uses a modern web application to streamline the on-demand delivery of key documentation for each fluid product.


BATAVIA, Ill. (PRWEB)

New Interactive Product Platform from Radco Industries

Xceltherm Heat Transfer Fluid Properties, Usage, and Safety Data Available On Demand

Radco Industries, a functional fluids manufacturer based in Batavia, Illinois, USA has been involved with heat transfer fluids under the Xceltherm brand name since 1971. And beginning in 2003, they also added several flushing and system cleaning products for thermal-processing equipment maintenance.

Xceltherm Heat Transfer Fluids are used to control temperature in a wide variety of heating and cooling equipment and industrial processes, for manufacturing organic and inorganic chemicals, in gas processing and petroleum refining, in plastics, asphalt paving, textiles, pharmaceuticals, food manufacturing, solar energy, and more.

The fluids are based on a variety of chemistries and serve a wide range of temperatures (-100°F to +750°F) and application conditions. Sales engineers and customer service professionals assist end-users, OEMs and specifiers in selecting the right fluid for each application. However, with 22 different fluid products to choose from, in the past some customers have expressed frustration differentiating the products by name, by function, and for suitability to their specific needs. Now, there’s a solution to that problem.

Radco’s new Interactive Product Platform, at Radcoind.com uses a modern web application to streamline the on-demand delivery of key documentation for each fluid product. At the top of each product page, a simple embedded form allows the user to enter an email address, click a single submit button, and instantly receive, via email, all the important documents supporting that product—the physical properties and engineering data, the safety data, and in some cases, the recommended usage instructions.

In addition, each product page features a prominent column of direct links to these same documents for instant download, and the fluid directory page features an interactive temperature graphic displaying the recommended temperature service ranges for all the heat transfer fluids. Many users, however, prefer to use the autoresponder form to instantly receive a fluid’s dedicated documents. The instant email arriving in the inbox provides a convenient selection record, a reference point, and flags the specific product (or products) of interest. When several products from several distinct suppliers are being evaluated, an interactive product platform can deliver a handy way to register the top product candidates and organize them.

In addition, registering interest in a specific product, submitting the autoresponder form, and receiving the documents, will also save the entered email address in the database, and trigger a concise follow-up message a few days later. This no-pressure, short email is sent to confirm receipt of the documents, and ask if any further information is needed, if any questions remain, or if pricing or logistics are required. It also serves as a scheduled reminder, in case the professional who requested the information is juggling multiple projects and can use a nudge.

This web application also creates a unique mailing list for each product, which can be used for future product updates, alerts of new documentation, and product-specific news. As the Interactive Product Platform is new to Radco Industries, this last feature hasn’t been needed or used yet, at press time. All received messages contain an unsubscribe link at the bottom, so further communications from each list can be permanently cancelled at any time.

This same autoresponder platform is also available, with similar function, on the [Tech Tips section of the website where thermal-fluid users and specifiers can enter their names and emails to receive monthly tips on operation and maintenance of thermal fluids and related equipment and processes.

John Campbell

Radco Industries Inc.

Global Sales Manager

Xceltherm® Heat Transfer Fluids

Radco Industries Inc.

https://www.radcoind.com

https://www.radcoind.com/heat-transfer-fluids/

E-mail: jcampbell(at)radcoind.com

Phone: +1-630.232.7966

Share article on social media or email:



Source link

Society: Disabled Issues / Disabilities

Cumberland Academy of Georgia Partners with Kennesaw State University

Leave a comment


Two Cumberland Academy students at Kennesaw State University for dual enrollment

According to the executive director, Dr. Neil Duchac, “We are exceptionally pleased at the opportunity to work with students from the Cumberland. Their presence in this pilot program highlights our dedication to the community and our students.”


ATLANTA (PRWEB)

Cumberland Academy of Georgia, an Atlanta-based special needs school, is launching a new and innovative dual enrollment program in partnership with Kennesaw State University. Cumberland’s “Creating Futures” program will be working with KSU’s “Academy for Inclusive Learning and Social Growth” to provide Cumberland’s Career Prep high school seniors with the experience of attending and studying at the college level in the certificate based program. This pilot dual enrollment program will bridge the gap between the Cumberland academic program and the Kennesaw State University Inclusive Learning program.

Once a week, a group of Cumberland’s Career Prep seniors will visit KSU and participate in their academic program. The students will be integrated into the program, taking a class with other college students. Cumberland students will be assigned KSU mentors, attend social events and complete homework as required by the class. The Cumberland seniors will receive support with adapting to the expectations of college life and feeling a sense of comfort when attending social activities like football games and tailgate gatherings.

“Cumberland is uniquely poised to participate in a pilot program as we are always seeking additional experiences to assist students with their academic and social goals. This new dual enrollment experience will help our students ease into a college experience. We are grateful to the Academy for Inclusive Learning and Social Growth for this opportunity,” said Shari Wright, director of Student Advancement at Cumberland. “Students will train to become proficient in a specific skill and receive a certificate of completion. This program provides students with learning differences an opportunity to experience college and be well prepared for full enrollment in the college program upon graduation.”

The staff at KSU agree. “We are exceptionally pleased at the opportunity to work with students from Cumberland Academy of Georgia. Their presence in this pilot program highlights our dedication to the community and our students,” said Dr. Neil Duchac, executive director of the Academy of Inclusive Learning and Social Growth at Kennesaw State University.

About Cumberland Academy of Georgia

Cumberland Academy of Georgia specializes in the needs of students in grades 4 through 12 who have high-functioning autism, Asperger’s syndrome, attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD) and learning disabilities. Cumberland was founded in 2007 by Debbi and Matthew Scarborough, and is a fully-accredited, independent, non-profit school that seeks to provide a safe and supportive academic atmosphere for its students. Cumberland accepts applications year-round. To schedule a family tour, please contact Jane Paoletta, Director of Admissions, at 404-835-9000, or email admissions@cumberlandacademy.org.

Share article on social media or email:



Source link

Lifestyle: Self Help

Brothers Van Patten Parlay Real-Life Prop Bet Into Movie ‘Gem’

Leave a comment


Winner of Best Comedy at CAIFF

The Van Patten brothers new movie.
Winner of Best Comedy at CAIFF.

“Funny, fresh, insightful and entertaining as hell.” ~ Richard Roeper


LOS ANGELES (PRWEB)

Vincent Van Patten and his brother James Van Patten are Hollywood legacy – sons of beloved Eight Is Enough patriarch Dick Van Patten and members of an entertainment family comprised of actors, directors and filmmakers. Dick would host weekly poker games for Hollywood’s elite and it was almost mandatory that Vincent and James learned the game and participated – often being instructed to miss school to play another hand.

The Van Patten brothers have carved out impressive careers for themselves. Both grew up on screen… After appearing in a slew of movies and TV including Apple’s Way and Three For The Road, Vincent gained fame as an international tennis champion and is the longtime host/commentator of The World Poker Tour. An accomplished actor/writer/producer, James has appeared in over 40 films including his starring role in Young Warriors for which he received critical acclaim, and his role as Dr. Heffner in the SAW movies.

It’s no surprise that the Van Pattens’ new feature is pretty much founded in fact. Rolling into theaters on September 20th from Gravitas Ventures, 7 Days To Vegas is based on an actual ‘prop bet’ and true outrageous adventure. Dubbed “A charming, dryly funny, low-key gem” by Chicago Sun Times film critic Richard Roeper, the movie mixes comedy and gambling as Duke (Vincent Van Patten) sets out to win a wager that he can walk from Los Angeles to Las Vegas in 7 days… with all his friends betting against him. In addition to James Van Patten, the eccentric characters that co-star include Ross McCall (Band of Brothers), Paul Walter Hauser (title role in Clint Eastwood’s upcoming The Ballad of Richard Jewell, BlackkKlansman, I Tonya), Emmy Award winning Eileen Davidson (The Young and the Restless), Don Stark (Green Book), Lucas Bryant (Haven), John O’Hurley (Seinfeld), Chad Lowe (Pretty Little Liars), Willie Garson (Sex and the City) and Jennifer Tilly (Bound, Bride of Chucky).

Best described as The Sting meets The Hangover, Vincent co-wrote with Steve Alper and produced with James, then they teamed up with producers Kim Waltrip (Hit & Run) and The World Poker Tour winner Adam Weinraub. The World Poker Tour also co-produced and is promoting the film’s nationwide release on September 20th with premiere events in Los Angeles, Las Vegas, New York and Chicago. 7 Days To Vegas is already a top pre-seller on iTunes with the video-on-demand release scheduled for late September.

“This film incorporates our love of making movies, poker, and honors our father, Dick Van Patten, who would love 7 Days To Vegas,” says James. “It doesn’t get much better, especially making it together. It’s a royal flush!”

Official website: https://www.7daystovegas.com

Link to Pre-Buy: iTunes

Follow on Facebook, Instagram and Twitter

*Interviews available    *additional artwork & stills available

# # #

Share article on social media or email:





Source link

Press Release News Wire Service